AAAAAA
Results:
1-7
|
Results: 7
Authors:
Lina, B
Fletcher, MA
Valette, M
Saliou, P
Aymard, M
Citation: B. Lina et al., A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European community for immunogenicity, in children, adults and the elderly, BIOLOGICALS, 28(2), 2000, pp. 95-103
Authors:
Valette, M
Aymard, M
Citation: M. Valette et M. Aymard, Variability of influenza symptomatology, ARCH PED, 7, 2000, pp. 479S-482S
Authors:
Senneville, E
Rivaud, E
Valette, M
Maulin, L
Yasdanpanah, Y
Ajana, F
Alfandari, S
Gerard, Y
Behra, JM
Caillaux, M
Chidiac, C
Mouton, Y
Citation: E. Senneville et al., Non-pulmonary parameters associated to varicella pneumonia in healthy adults., MED MAL INF, 30(4), 2000, pp. 211-216
Authors:
de la Tribonniere, X
Valette, M
Alfandari, S
Citation: X. De La Tribonniere et al., Oral nitazoxanide and paromomycin inhalation for systemic cryptosporidiosis in a patient with AIDS, INFECTION, 27(3), 1999, pp. 232-232
Authors:
Aymard, M
Valette, M
Lina, B
Thouvenot, D
Citation: M. Aymard et al., Surveillance and impact of influenza in Europe, VACCINE, 17, 1999, pp. S30-S41
Authors:
Magnard, C
Valette, M
Aymard, M
Lina, B
Citation: C. Magnard et al., Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses, J MED VIROL, 59(2), 1999, pp. 215-220
Authors:
Layani-Milon, MP
Gras, I
Valette, M
Luciani, J
Stagnara, J
Aymard, M
Lina, B
Citation: Mp. Layani-milon et al., Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods, J CLIN MICR, 37(6), 1999, pp. 1721-1726
Risultati:
1-7
|